Please login to the form below

Not currently logged in
Email:
Password:

Crescendo Biologics appoints Edward Stewart as chief business officer

He joins the Cambridge, UK-based firm from Merrimack Pharmaceuticals

Biopharmaceutical group Crescendo Biologics has appointed Edward Stewart as its new chief business officer.

Stewart joins the Cambridge, UK-based firm from Merrimack Pharmaceuticals, where he served in several executive roles, including leading the commercial business unit and the business development function.

He said: “Crescendo is developing very exciting and highly differentiated pipeline of therapeutics.

“I look forward to joining the team and contributing my experience to advance those products, achieve our corporate goals and realise the full potential of the Humabody platform.”

Stewart has over 20 years’ of experience working in the biotechnology field and his expertise lies in growing pre-clinical organisations to commercial enterprises and market launches.

Peter Pack, CEO of Crescendo Biologics, said: “A strong and experienced team is key to reaching our ambitions and Stewart brings broad experience in business and corporate development as well as organisational growth, making him a great addition to our leadership team.”

20th June 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics